Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists
P., Kesslak, J
Changes in Bone Mineral Density, Body Composition, and Lipid Metabolism During Growth Hormone (GH) Treatment in Children With GH Deficiency
Similar side effects of Wegovy and ADHD medications Wegovy, Adderall, and other ADHD medications, These symptoms may reduce your nutrient intake, which may lead to weight loss
Cerebrolysin for neuropathy and neurological recovery Cerebrolysin occupies a unique position among neuropathy-relevant peptides
Activation of Wnt/-catenin signaling in basal epithelial cells by locally expressed Wnt ligands is both necessary and sufficient to induce placode formation (van Genderen et al., 1994
